MapLight Therapeutics Inc. Gains 31.26%
Wed, Dec 03, 2025 at 07:41 PM
MapLight Therapeutics Inc. (MPLT:NASDAQ) jumped higher at $16.92, representing a gain of 31.3%. On Wed, Dec 03, 2025, MPLT:NASDAQ touched a New 2-Week High of $16.92. The stock got featured on our News Catalysts scanner on Fri, Nov 21, 2025 at 06:02 PM in the 'PUBLIC OFFERING' category. From Thu, Nov 20, 2025, the stock recorded 50.00% Up Days and 44.44% Green Days
About MapLight Therapeutics Inc. (MPLT:NASDAQ)
MapLight Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders.
Top 10 Gainers:
- Smart for Life, Inc. (SMFL:NASDAQ), 1780%
- Capricor Therapeutics, Inc. (CAPR:NASDAQ), 371.07%
- Nauticus Robotics, Inc. (KITT:NASDAQ), 115.89%
- Virax Biolabs Group Limited (VRAX:NASDAQ), 75.11%
- iRobot Corporation (IRBT:NASDAQ), 73.85%
- Micropolis Holding Company (MCRP:NYSEMKT), 51.28%
- Q/C Technologies Inc Com Par $0.001 (QCLS:NASDAQ), 38.17%
- Kaixin Holdings (KXIN:NASDAQ), 33.87%
- Kazia Therapeutics Limited (KZIA:NASDAQ), 31.71%
- MapLight Therapeutics Inc. (MPLT:NASDAQ), 31.26%